company background image
AJANTPHARM logo

Ajanta Pharma NSEI:AJANTPHARM 주식 보고서

최종 가격

₹2.95k

시가총액

₹367.9b

7D

3.0%

1Y

50.1%

업데이트

21 Nov, 2024

데이터

회사 재무 +

Ajanta Pharma Limited

NSEI:AJANTPHARM 주식 보고서

시가총액: ₹367.9b

AJANTPHARM 주식 개요

전문 의약품 제제 회사인 아잔타 파마는 자회사와 함께 전문 의약품 완제의약품을 개발, 제조 및 판매하고 있습니다. 자세한 내용

AJANTPHARM 기본 분석
눈송이 점수
가치 평가1/6
미래 성장3/6
과거 실적6/6
재무 상태6/6
배당금5/6

Ajanta Pharma Limited 경쟁사

가격 내역 및 성능

다음에 대한 모든 사상 최고가, 변동 및 가격 하락 요약 Ajanta Pharma
과거 주가
현재 주가₹2,945.50
52주 최고치₹3,485.00
52주 최저치₹1,850.25
베타0.10
11개월 변경-1.07%
3개월 변경 사항-5.09%
1년 변경 사항50.12%
33년 변화111.60%
5년 변화341.87%
IPO 이후 변화18,706.40%

최근 뉴스 및 업데이트

Revenue Beat: Ajanta Pharma Limited Exceeded Revenue Forecasts By 5.3% And Analysts Are Updating Their Estimates

Oct 31
Revenue Beat: Ajanta Pharma Limited Exceeded Revenue Forecasts By 5.3% And Analysts Are Updating Their Estimates

Here's Why Ajanta Pharma (NSE:AJANTPHARM) Has Caught The Eye Of Investors

Sep 10
Here's Why Ajanta Pharma (NSE:AJANTPHARM) Has Caught The Eye Of Investors

Recent updates

Revenue Beat: Ajanta Pharma Limited Exceeded Revenue Forecasts By 5.3% And Analysts Are Updating Their Estimates

Oct 31
Revenue Beat: Ajanta Pharma Limited Exceeded Revenue Forecasts By 5.3% And Analysts Are Updating Their Estimates

Here's Why Ajanta Pharma (NSE:AJANTPHARM) Has Caught The Eye Of Investors

Sep 10
Here's Why Ajanta Pharma (NSE:AJANTPHARM) Has Caught The Eye Of Investors

We Think Ajanta Pharma (NSE:AJANTPHARM) Can Manage Its Debt With Ease

Aug 23
We Think Ajanta Pharma (NSE:AJANTPHARM) Can Manage Its Debt With Ease

Ajanta Pharma Limited Just Recorded A 11% EPS Beat: Here's What Analysts Are Forecasting Next

Aug 04
Ajanta Pharma Limited Just Recorded A 11% EPS Beat: Here's What Analysts Are Forecasting Next

Some Confidence Is Lacking In Ajanta Pharma Limited's (NSE:AJANTPHARM) P/E

Aug 01
Some Confidence Is Lacking In Ajanta Pharma Limited's (NSE:AJANTPHARM) P/E

With EPS Growth And More, Ajanta Pharma (NSE:AJANTPHARM) Makes An Interesting Case

Jun 01
With EPS Growth And More, Ajanta Pharma (NSE:AJANTPHARM) Makes An Interesting Case

Ajanta Pharma Limited (NSE:AJANTPHARM) Analysts Are Pretty Bullish On The Stock After Recent Results

May 05
Ajanta Pharma Limited (NSE:AJANTPHARM) Analysts Are Pretty Bullish On The Stock After Recent Results

Ajanta Pharma Limited's (NSE:AJANTPHARM) Intrinsic Value Is Potentially 23% Below Its Share Price

Apr 05
Ajanta Pharma Limited's (NSE:AJANTPHARM) Intrinsic Value Is Potentially 23% Below Its Share Price

We Think Ajanta Pharma (NSE:AJANTPHARM) Can Manage Its Debt With Ease

Feb 23
We Think Ajanta Pharma (NSE:AJANTPHARM) Can Manage Its Debt With Ease

Ajanta Pharma Limited (NSE:AJANTPHARM) Investors Are Less Pessimistic Than Expected

Dec 23
Ajanta Pharma Limited (NSE:AJANTPHARM) Investors Are Less Pessimistic Than Expected

Ajanta Pharma (NSE:AJANTPHARM) Seems To Use Debt Quite Sensibly

Aug 26
Ajanta Pharma (NSE:AJANTPHARM) Seems To Use Debt Quite Sensibly

These 4 Measures Indicate That Ajanta Pharma (NSE:AJANTPHARM) Is Using Debt Reasonably Well

Feb 07
These 4 Measures Indicate That Ajanta Pharma (NSE:AJANTPHARM) Is Using Debt Reasonably Well

Here's Why Ajanta Pharma (NSE:AJANTPHARM) Has Caught The Eye Of Investors

Oct 24
Here's Why Ajanta Pharma (NSE:AJANTPHARM) Has Caught The Eye Of Investors

Estimating The Intrinsic Value Of Ajanta Pharma Limited (NSE:AJANTPHARM)

Aug 25
Estimating The Intrinsic Value Of Ajanta Pharma Limited (NSE:AJANTPHARM)

Is Now The Time To Put Ajanta Pharma (NSE:AJANTPHARM) On Your Watchlist?

Jul 19
Is Now The Time To Put Ajanta Pharma (NSE:AJANTPHARM) On Your Watchlist?

A Look At The Intrinsic Value Of Ajanta Pharma Limited (NSE:AJANTPHARM)

Apr 28
A Look At The Intrinsic Value Of Ajanta Pharma Limited (NSE:AJANTPHARM)

Ajanta Pharma (NSE:AJANTPHARM) Seems To Use Debt Quite Sensibly

Mar 14
Ajanta Pharma (NSE:AJANTPHARM) Seems To Use Debt Quite Sensibly

I Built A List Of Growing Companies And Ajanta Pharma (NSE:AJANTPHARM) Made The Cut

Feb 06
I Built A List Of Growing Companies And Ajanta Pharma (NSE:AJANTPHARM) Made The Cut

Estimating The Fair Value Of Ajanta Pharma Limited (NSE:AJANTPHARM)

Dec 13
Estimating The Fair Value Of Ajanta Pharma Limited (NSE:AJANTPHARM)

Ajanta Pharma (NSE:AJANTPHARM) Will Pay A Dividend Of ₹9.50

Oct 31
Ajanta Pharma (NSE:AJANTPHARM) Will Pay A Dividend Of ₹9.50

Here's Why We Think Ajanta Pharma (NSE:AJANTPHARM) Is Well Worth Watching

Sep 22
Here's Why We Think Ajanta Pharma (NSE:AJANTPHARM) Is Well Worth Watching

Is Ajanta Pharma Limited (NSE:AJANTPHARM) Trading At A 27% Discount?

Sep 08
Is Ajanta Pharma Limited (NSE:AJANTPHARM) Trading At A 27% Discount?

Does Ajanta Pharma (NSE:AJANTPHARM) Have A Healthy Balance Sheet?

Aug 26
Does Ajanta Pharma (NSE:AJANTPHARM) Have A Healthy Balance Sheet?

Here's Why Shareholders Will Not Be Complaining About Ajanta Pharma Limited's (NSE:AJANTPHARM) CEO Pay Packet

Jul 07
Here's Why Shareholders Will Not Be Complaining About Ajanta Pharma Limited's (NSE:AJANTPHARM) CEO Pay Packet

Should You Be Adding Ajanta Pharma (NSE:AJANTPHARM) To Your Watchlist Today?

Jun 14
Should You Be Adding Ajanta Pharma (NSE:AJANTPHARM) To Your Watchlist Today?

Is Ajanta Pharma Limited (NSE:AJANTPHARM) Trading At A 30% Discount?

May 15
Is Ajanta Pharma Limited (NSE:AJANTPHARM) Trading At A 30% Discount?

Ajanta Pharma Limited (NSE:AJANTPHARM) Vies For A Place In Your Dividend Portfolio: Here's Why

Apr 10
Ajanta Pharma Limited (NSE:AJANTPHARM) Vies For A Place In Your Dividend Portfolio: Here's Why

Ajanta Pharma Limited's (NSE:AJANTPHARM) Has Had A Decent Run On The Stock market: Are Fundamentals In The Driver's Seat?

Mar 11
Ajanta Pharma Limited's (NSE:AJANTPHARM) Has Had A Decent Run On The Stock market: Are Fundamentals In The Driver's Seat?

Does Ajanta Pharma (NSE:AJANTPHARM) Deserve A Spot On Your Watchlist?

Feb 24
Does Ajanta Pharma (NSE:AJANTPHARM) Deserve A Spot On Your Watchlist?

The Ajanta Pharma (NSE:AJANTPHARM) Share Price Is Up 56% And Shareholders Are Holding On

Jan 30
The Ajanta Pharma (NSE:AJANTPHARM) Share Price Is Up 56% And Shareholders Are Holding On

What Can We Make Of Ajanta Pharma's (NSE:AJANTPHARM) CEO Compensation?

Jan 18
What Can We Make Of Ajanta Pharma's (NSE:AJANTPHARM) CEO Compensation?

Estimating The Fair Value Of Ajanta Pharma Limited (NSE:AJANTPHARM)

Jan 06
Estimating The Fair Value Of Ajanta Pharma Limited (NSE:AJANTPHARM)

주주 수익률

AJANTPHARMIN PharmaceuticalsIN 마켓
7D3.0%-0.2%0.3%
1Y50.1%40.5%27.3%

수익률 대 산업: AJANTPHARM 지난 1년 동안 40.5 %를 반환한 Indian Pharmaceuticals 산업을 초과했습니다.

수익률 대 시장: AJANTPHARM 지난 1년 동안 27.3 %를 반환한 Indian 시장을 초과했습니다.

가격 변동성

Is AJANTPHARM's price volatile compared to industry and market?
AJANTPHARM volatility
AJANTPHARM Average Weekly Movement5.2%
Pharmaceuticals Industry Average Movement6.0%
Market Average Movement6.1%
10% most volatile stocks in IN Market9.2%
10% least volatile stocks in IN Market4.0%

안정적인 주가: AJANTPHARM 는) 지난 3개월 동안 큰 가격 변동성이 없었습니다.

시간에 따른 변동성: AJANTPHARM 의 주간 변동성( 5% )은 지난 1년 동안 안정적인 모습을 보였습니다.

회사 소개

설립직원CEO웹사이트
19738,073Yogesh Agrawalwww.ajantapharma.com

전문 의약품 제제 회사인 Ajanta Pharma Limited는 자회사와 함께 전문 의약품 완제의약품을 개발, 제조 및 판매합니다. 이 회사는 심장학, 항당뇨, 안과, 피부과, 통증 관리, 호흡기 분야 등 다양한 치료 분야를 마케팅하고 서비스를 제공합니다. 또한 정제, 캡슐, 주사제, 흡입기, 연고, 크림, 액상 제품도 제공합니다.

Ajanta Pharma Limited 기본 사항 요약

Ajanta Pharma 의 수익과 매출은 시가총액과 어떻게 비교하나요?
AJANTPHARM 기본 통계
시가총액₹367.86b
수익(TTM)₹8.75b
수익(TTM)₹44.91b

42.0x

P/E 비율

8.2x

P/S 비율

AJANTPHARM 주가가 과대평가되어 있나요?

공정 가치 및 가치 분석 보기

수익 및 수익

최신 수익 보고서의 주요 수익성 통계(TTM)
AJANTPHARM 손익 계산서(TTM)
수익₹44.91b
수익 비용₹11.43b
총 이익₹33.48b
기타 비용₹24.73b
수익₹8.75b

최근 보고된 수익

Sep 30, 2024

다음 수익 날짜

n/a

주당 순이익(EPS)70.06
총 마진74.56%
순이익 마진19.48%
부채/자본 비율0.07%

AJANTPHARM 의 장기적인 성과는 어땠나요?

과거 실적 및 비교 보기

배당금

1.9%

현재 배당 수익률

78%

지급 비율

AJANTPHARM 신뢰할 수 있는 배당금을 지급하나요?

AJANTPHARM 배당 내역 및 벤치마크 참조
예정된 배당금을 받으려면 언제까지 AJANTPHARM 을 구매해야 하나요?
Ajanta Pharma 배당 날짜
전 배당일Nov 06 2024
배당금 지급일Nov 27 2024
전 배당금까지의 일수16 days
배당금 지급일까지의 일수5 days

AJANTPHARM 신뢰할 수 있는 배당금을 지급하나요?

AJANTPHARM 배당 내역 및 벤치마크 참조